Active ingredient
Ceftaroline Fosamil
6 finished FDA listings contain Ceftaroline Fosamil as their only active ingredient.
FDA NDC Directory
- Ingredient names as written by FDA
- CEFTAROLINE FOSAMIL
- Dosage forms
- Injection, Powder, Lyophilized, For Solution, Powder, For Solution
- Routes
- Intravenous
- Manufacturers / labelers
- 2
- Strengths listed
- 400 mg/20ml · 600 mg/20ml
- Brand names in FDA listings
- Teflaro
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 1040004
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| NDA 200327 | ABBVIE | 2010-10-29 | 2 |
| ANDA 208075 | APOTEX | 2021-09-21 | 4 |
Official labeling on DailyMed
- CEFTAROLINE FOSAMIL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [APOTEX CORP.] · version 7 · 2026-06-30
- TEFLARO (CEFTAROLINE FOSAMIL) POWDER, FOR SOLUTION [ALLERGAN, INC.] · version 43 · 2025-11-17
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.